BioGeometry Raises $100 Million to Scale AI Models That Design Drugs From Scratch
Read the full story on VentureburnOn average, it takes about 10-15 years to produce a new drug. Artificial intelligence could rewrite how new drugs are discovered as BioGeometry raises $100 million. The Beijing-based startup closed
This story was written and published by Ventureburn. Business.co.za shows its headline and teaser from the publisher’s RSS feed and links to the original.